Public Health and Public Trust – The Reputation of Nordic Pharma

Time: Thursday, June 26, 1:00–1:55 p.m.

Confidence in the pharmaceutical industry is vital to public health—but trust is fragile. What drives confidence in a sector shaped by high expectations and strict regulation? And what happens when trust in the Nordic pharmaceutical industry begins to erode?

Join us live at Almedalen or via Teams. The event will take place on a historic sailing ship! You’ll find the schooner Svanhild af Borgå docked at Österdahls Brygga in the port of Visby. Please register for the seminar below and make sure you receive a confirmation email.

The pharmaceutical industry plays a crucial role in public health, yet trust in companies remains fragile. While innovation and life-saving treatments drive progress, concerns about pricing, transparency, and corporate ethics continue to shape public perception. What builds confidence in this highly regulated sector, and what erodes it?

Reputation and Trust Analytics presents findings from a comprehensive study on trust in pharmaceutical companies across the Nordic countries. The analysis highlights how reputation influences stakeholder behavior. How can the industry balance innovation with accountability? What role do communication, policy, and corporate responsibility play in building trust?

Participants

Edvard Agrell, Corporate Public Affairs Manager, Bayer

Erik Kjellin, Head of Press, Lif – The Research-Based Pharmaceutical Companies

Pia Steensland, Director of Policy & Public Affairs, Pfizer Sweden

Tobias Lundin Gerdås, Partner, Policy and Government Affairs, Roche Sweden

Sofia Rydgren Stale, President, Finnish Medical Association

Andrei Sergejeff, Senior Advisor, Reputation and Trust Analytics

Peter Markström, Advisor, Reputation and Trust Analytics

Andrei Sergejeff, Senior Advisor, Reputation and Trust Analytics